LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
5.34
-0.05 (-1.02%)
Oct 15, 2026, 3:30 PM EDT - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $50.26 million as of October 15, 2026. It is the 30,156th most valuable company in the world and the 4,633rd biggest in the United States. Its market cap has increased by 240.77% in one year.
Market Cap
50.26M
Enterprise Value
-225.43K
1-Year Change
240.77%
Global Rank
Country Rank
#4,633 United States
Category
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $50.26M, a decrease of -90.47%. That is a compound annual growth rate of -32.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 50.26M | 68.36% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pliant Therapeutics | 61.47M |
| Adicet Bio | 60.28M |
| Xilio Therapeutics | 59.81M |
| Alps Group | 59.04M |
| Fractyl Health | 58.37M |
| iBio, Inc. | 58.13M |
| Eloxx Pharmaceuticals | 58.02M |
| Connect Biopharma Holdings | 57.84M |